Back to Newsroom
Back to Newsroom

SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues To Investigate Whether The Sale Of These Companies Is Fair To Shareholders - MCRN, DOVA, AVDR

Thursday, 24 October 2019 09:35 AM

Halper Sadeh LLP

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / October 24, 2019 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

Milacron Holdings Corp. (NYSE:MCRN)

The investigation concerns whether Milacron and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Milacron to Hillenbrand, Inc. for $11.80 in cash and 0.1612 shares of Hillenbrand common stock for each share of Milacron common stock. If you are a Milacron shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/milacron-holdings-corp-mcrn-merger-stock-hillenbrand/.

Dova Pharmaceuticals, Inc. (NASDAQ:DOVA)

The investigation concerns whether Dova and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Dova to Swedish Orphan Biovitrum AB. Under the terms of the agreement, Dova shareholders will be offered an upfront payment for $27.50 per share in cash and one non-tradeable Contingent Value Right to an additional $1.50 per share in cash upon regulatory approval of DOPTELET. If you are a Dova shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/dova-pharmaceuticals-inc-sobi-stock-merger-swedish/.

Avedro, Inc. (NASDAQ:AVDR)

The investigation concerns whether Avedro and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Avedro to Glaukos Corporation. Under the terms of the merger agreement, Avedro shareholders will receive an exchange ratio equivalent of 0.365 shares of Glaukos stock for each share of Avedro common stock. If you are an Avedro shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/avedro-inc-avdr-stock-merger-glaukos/.

On behalf of shareholders of these companies, Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: